Home » Topics » BioWorld Science

BioWorld Science
RSS

Flash Therapeutics created from Vectalys and FlashCell merger

May 17, 2018

Emulate and AstraZeneca enter Organs-on-Chips technology agreement

May 17, 2018

FDA accepts Turnstone Biologics' IND for MG1-HPV

May 17, 2018

FDA approves Lucemyra to mitigate opioid withdrawal symptoms

May 17, 2018

EC approves Repatha for prevention of heart attack and stroke in established cardiovascular disease

May 17, 2018

Caladrius Biosciences initiates phase II study of CLBS-14

May 17, 2018

FogPharma announces closing of series B financing

May 17, 2018

Hospira obtains FDA approval for epoetin alfa biosimilar Retacrit

May 17, 2018

SNP in ITGA4 gene tied to higher risk of Alzheimer's disease

May 17, 2018

Preliminary results reported from phase Ia/b study of LY-3300054 for solid tumors

May 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...